Life Sciences Insight

Digital Health Startup Scores Big Bucks

It’s a great time to be working in the digital health space. Adoption of digital health solutions are at an all-time high, and venture capital firms are eager to find the next Pear Therapeutics.

The latest digital health company to benefit from investor interest in this space is Toronto, Ontario-based Xandar Kardian, which just closed a $10 million series A round. Phoenix Venture Partners, Portfolia Active Aging & Longevity Fund, and Taronga Ventures were among the lead investors on this round.

The digital health startup developed the XK300 autonomous health monitoring solution (pictured below), which is an FDA-cleared device designed to provide contact-free, continuous vital sign monitoring, such as heart rate and respiratory rate.Image courtesy of Xandar Kardiandigital health technology for vital sign monitoring

“At Xandar Kardian, our goal is to enable predictive and preventive care for people everywhere by leveraging the advanced technologies available today. Our radar-based solutions are the future of healthcare and patient monitoring, allowing providers to take continuous vital sign measurements without any intervention, a true breakthrough that will save lives,” said Sam Yang, the company’s CEO and founder.

Xandar Kardian’s radar technology is also intended to provide commercial and public building operators with reliable real-time occupancy measurements for more effective energy optimization versus antiquated PIR (passive infrared) motion sensor systems. The company says its technologies provide 99.9% accuracy in presence detection and up to 92% in occupancy counting via vital sign measurement.

Yang said the proceeds of the series A funding will support the commercial rollout of our healthcare solutions and the expansion of the company’s RealTech business. Yang founded the digital health company in 2017 with the intention of deploying reliable and high-accuracy cleantech, smart building and healthcare solutions worldwide.

“We’re thrilled to partner with the Xandar Kardian team,” said Zach Jonasson, co-founder and managing general partner of Phoenix Venture Partners. “Xandar Kardian’s groundbreaking technology and visionary team are well-positioned to enable truly frictionless and actionable health monitoring in healthcare facilities and at home.”

FDA cleared the XK300 in April, and the digital health startup received the CES Innovation Award at the Consumer Electronics Show (CES) this year for its autonomous health monitoring solution.

SHARE
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn